Pro-Dex, Inc. (PDEX)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 66,593,000 23.7%
- Net income
- 8,978,000 322.1%
- Gross profit
- 19,510,000
- Operating income
- 10,689,000
- Earnings per share
- 2.67 345%
- R&D expense
- 3,636,000
Growth and profitability
- Gross margin
- 29.30
- Operating margin
- 16.05
- Net margin
- 13.48
- Return on equity
- 24.51
- Return on assets
- 14.67
- Free cash flow margin
- -4.40
Balance sheet
- Total assets
- 61,192,000
- Total liabilities
- 24,560,000
- Shareholders' equity
- 36,632,000
- Cash and equivalents
- 419,000
- Debt
- 15,431,000
- Net debt
- 15,012,000
- Current ratio
- 3.23
- Debt to equity
- 0.42
Cash flow and ratios
- Operating cash flow
- -1,682,000
- Free cash flow
- -2,928,000
Shareholder returns
- Share buybacks
- 3,504,000
- Shares outstanding
- 3,200,001
- Book value per share
- 11.45
Company information
- Headquarters
- Irvine, CA
- Exchange
- NASDAQ
- Fiscal year end
- 06-30
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
Pro-Dex, Inc. trades on NASDAQ under the ticker symbol PDEX. This page brings together its price chart, company profile, key financial figures and technical indicators.